ACCESSION: MSBNK-SMB_Measured-HSA015P0305002
RECORD_TITLE: Characterized; N-Acetylaspartylglutamic acid; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 19
COMMENT: RAW_SPEC {'EL02_pos_1996': {'bp': 118879.0, 'sum': 498026.0}, 'EL05_pos_1995': {'bp': 78950.0, 'sum': 367601.0}, 'EL16_pos_1995': {'bp': 74889.0, 'sum': 363921.0}, 'EL14_pos_1997': {'bp': 73375.0, 'sum': 308205.0}, 'EL01_pos_1990': {'bp': 68352.0, 'sum': 293191.0}, 'EL18_pos_1990': {'bp': 67081.0, 'sum': 309392.0}, 'EL06_pos_1991': {'bp': 67010.0, 'sum': 293679.0}, 'EL10_pos_1996': {'bp': 62739.0, 'sum': 263613.0}, 'EL15_pos_1995': {'bp': 61582.0, 'sum': 288976.0}, 'EL20_pos_1984': {'bp': 58760.0, 'sum': 258289.0}, 'EL17_pos_1979': {'bp': 58606.0, 'sum': 245110.0}, 'EL24_pos_2007': {'bp': 57091.0, 'sum': 280856.0}, 'EL04_pos_1995': {'bp': 54244.0, 'sum': 272572.0}, 'EL13_pos_1991': {'bp': 51190.0, 'sum': 240391.0}, 'EL07_pos_1990': {'bp': 48955.0, 'sum': 195776.0}, 'EL22_pos_2008': {'bp': 47472.0, 'sum': 218327.0}, 'EL12_pos_1997': {'bp': 43608.0, 'sum': 194452.0}, 'EL23_pos_1995': {'bp': 38361.0, 'sum': 197498.0}, 'EL11_pos_1990': {'bp': 36322.0, 'sum': 160254.0}}
COMMENT: RETENTION_TIME_STDEV 0.008
COMMENT: PRECURSOR_M/Z_RAW 305.097904
COMMENT: PRECURSOR_M/Z_STDEV 0.000097
COMMENT: PRECURSOR_IN_MS1 mz 305.097896; int 48.123; delta(ppm) 1.326947
COMMENT: PROPOSED_CHARGE_STATE +1; mz 306.101085; int 6.099; cor 0.751
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+Na; mz 327.079782; int 12.483; cor 0.932
COMMENT: PROPOSED_ION_FORM M+Na; M+2Na-H; mz 327.079782; int 12.483; cor 0.932
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.148; C11H16N2O8; [M+H]+; delta(ppm) -0.147982
COMMENT: PROPOSED_MF SevenGoldenRules 3.907; C15H18N2OP2; [M+H]+; delta(ppm) 3.906730
COMMENT: PROPOSED_MF SevenGoldenRules 2.219; C8H19N4O5P; [M+Na]+; delta(ppm) -2.219003
COMMENT: PROPOSED_MF MS-FINDER 3.915; C11H16N2O8; [M+H]+; delta(ppm) -0.147274
COMMENT: PROPOSED_MF MS-FINDER 3.378; C10H14N6O4; [M+Na]+; delta(ppm) 30352.616254
COMMENT: PROPOSED_MF MS-FINDER 2.945; C12H12N6O4; [M+H]+; delta(ppm) -4.530811
COMMENT: PROPOSED_MF MS-FINDER 2.938; C12H20N2O3S2; [M+H]+; delta(ppm) -2.995589
COMMENT: PROPOSED_MF MS-FINDER 2.929; C13H21O4PS; [M+H]+; delta(ppm) 2.639849
COMMENT: PROPOSED_MF MS-FINDER 2.787; C8H19N4O5P; [M+Na]+; delta(ppm) 30346.868756
COMMENT: PROPOSED_MF MS-FINDER 2.617; C5H17N6O7P; [M+H]+; delta(ppm) 3.240372
COMMENT: PROPOSED_MF MS-FINDER 2.598; C6H13N10O3P; [M+H]+; delta(ppm) -1.143194
COMMENT: PROPOSED_MF MS-FINDER 2.384; C18H18OS; [M+Na]+; delta(ppm) 30351.978728
COMMENT: PROPOSED_MF MS-FINDER 2.283; C6H21N6O2PS2; [M+H]+; delta(ppm) 0.392038
COMMENT: PROPOSED_MF MS-FINDER 2.223; C8H27O4PS2; [M+Na]+; delta(ppm) 30348.498585
COMMENT: PROPOSED_MF MS-FINDER 2.205; C4H16N8O6S; [M+H]+; delta(ppm) -2.395073
COMMENT: PROPOSED_MF MS-FINDER 1.969; C11H10N10; [M+Na]+; delta(ppm) 30347.962575
COMMENT: PROPOSED_MF MS-FINDER 1.927; C8H8N12O2; [M+H]+; delta(ppm) 4.270713
COMMENT: PROPOSED_MF SIRIUS5_Sirius 40.805; C11H16N2O8; [M+H]+; delta(ppm) -0.147274
COMMENT: PROPOSED_MF SIRIUS5_Sirius 36.509; C12H12N6O4; [M+H]+; delta(ppm) -4.530811
COMMENT: PROPOSED_MF SIRIUS5_Sirius 34.413; C10H14N6O4; [M+Na]+; delta(ppm) 30352.616254
COMMENT: PROPOSED_MF SIRIUS5_Sirius 31.187; C10H17N4O5P; [M+H]+; delta(ppm) -9.944623
COMMENT: PROPOSED_MF SIRIUS5_Sirius 23.940; C12H20N2O3S2; [M+H]+; delta(ppm) -2.995589
COMMENT: PROPOSED_MF SIRIUS5_Sirius 23.336; C15H16N2O3S; [M+H]+; delta(ppm) 8.053798
COMMENT: PROPOSED_MF SIRIUS5_Sirius 22.903; C12H18BNO4S; [M+Na]+; delta(ppm) 66409.781278
COMMENT: PROPOSED_MF SIRIUS5_Sirius 18.164; C15H14N4O2; [M+Na]+; delta(ppm) 30338.618811
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.230; C14H18O6; [M+Na]+; delta(ppm) 30343.272405
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C13H13F3N4; [M+Na]+; delta(ppm) 30347.127295
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C12H14F6O2; [M+H]+; delta(ppm) 2.697101
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C20H16OS; [M+H]+; delta(ppm) -5.131324
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C20H13FO2; [M+H]+; delta(ppm) 2.172781
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C17H14F2O3; [M+H]+; delta(ppm) -1.572426
COMMENT: PROPOSED_MF SIRIUS5_Sirius -2.219; C13H21O4PS; [M+H]+; delta(ppm) 2.639849
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H14N6O4; [M+Na]+; delta(ppm) 30352.616254
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C11H16N2O8; [M+H]+; delta(ppm) -0.147274
COMMENT: PROPOSED_MF SIRIUS6_Sirius 58.061; C11H16N2O8; [M+H]+; delta(ppm) -0.147274
COMMENT: PROPOSED_MF SIRIUS6_Sirius 55.329; C12H12N6O4; [M+H]+; delta(ppm) -4.530811
COMMENT: PROPOSED_MF SIRIUS6_Sirius 52.541; C10H14N6O4; [M+Na]+; delta(ppm) 30352.616254
COMMENT: PROPOSED_MF SIRIUS6_Sirius 50.802; C12H17FN2O4S; [M+H]+; delta(ppm) 4.308547
COMMENT: PROPOSED_MF SIRIUS6_Sirius 47.249; C12H16N3O5; [M+Na]+; delta(ppm) 30347.944309
COMMENT: PROPOSED_MF SIRIUS6_Sirius 45.380; C8H17FN2O9; [M+H]+; delta(ppm) -3.892463
COMMENT: PROPOSED_MF SIRIUS6_Sirius 45.244; C9H18N2O8; [M+Na]+; delta(ppm) 30357.269976
COMMENT: PROPOSED_MF SIRIUS6_Sirius 44.533; C14H14N3O5; [M+H]+; delta(ppm) -8.931515
COMMENT: PROPOSED_MF SIRIUS6_Sirius 43.975; C14H13BFNO5; [M+H]+; delta(ppm) 33932.064567
COMMENT: PROPOSED_MF SIRIUS6_Sirius 43.902; C17H12BNO4; [M+H]+; delta(ppm) 33936.068264
COMMENT: PROPOSED_MF SIRIUS6_Sirius 43.504; C11H14BF2NO6; [M+H]+; delta(ppm) 33928.060901
COMMENT: PROPOSED_MF SIRIUS6_Sirius 42.306; C11H17FN2O5Si; [M+H]+; delta(ppm) -173267.161124
COMMENT: PROPOSED_MF SIRIUS6_Sirius 41.733; C9H18F2N2O5S; [M+H]+; delta(ppm) 0.563325
COMMENT: PROPOSED_MF SIRIUS6_Sirius 41.281; C9H19ClN4O4; [M+Na]+; delta(ppm) -46902.681346
COMMENT: PROPOSED_MF SIRIUS6_Sirius 40.727; C7H15FN6O5; [M+Na]+; delta(ppm) 30348.640262
COMMENT: PROPOSED_MF SIRIUS6_Sirius 40.206; C8H19N4O5P; [M+Na]+; delta(ppm) 30346.868756
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.703; C12H18BNO4S; [M+Na]+; delta(ppm) 66409.781278
COMMENT: PROPOSED_MF SIRIUS6_Sirius 38.887; C9H16BF2NO6; [M+Na]+; delta(ppm) 66413.828606
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.731; C10H15F3N3O3; [M+Na]+; delta(ppm) 30356.452947
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.722; C15H14N4O2; [M+Na]+; delta(ppm) 30338.618811
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C11H16N2O8; [M+H]+; delta(ppm) -0.147274
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.997; C10H14N6O4; [M+Na]+; delta(ppm) 30352.616254
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.003; C12H16N3O5; [M+Na]+; delta(ppm) 30347.944309
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.904; OPVPGKGADVGKTG-UHFFFAOYNA-N; [M+H]+; CC(=O)NC(CC(O)=O)C(=O)NC(CCC(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.794; GUCKKCMJTSNWCU-JHPDDGAFNA-N; [M+H]+; CC(=O)N[C@@H](CC(=O)N[C@H](CCC(O)=O)C(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.057; LHULZANLATXLRF-UWVGGRQHSA-N; [M+H]+; N[C@@H](CSCC=C)C(=O)N[C@@H](CSCC=C)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.050; RVTJMJBQQGMKMT-OXNFMAJFSA-N; [M+H]+; C1=C(C(C=NC1(C2C(C(C(O2)CO)O)O)O)(O)O)C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; DVFVNLSLZADOIQ-UHFFFAOYSA-N; [M+H]+; CCOC(=O)C1=C(C)C(C(=O)NC2=CC=CC=C2)=C(N)S1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.529; OPVPGKGADVGKTG-UHFFFAOYNA-N; [M+H]+; N-Acetylaspartylglutamic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.138; GUCKKCMJTSNWCU-JHPDDGAFNA-N; [M+H]+; (2R)-2-[[(3S)-3-acetamido-3-carboxy-1-oxopropyl]amino]pentanedioic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.127; RVTJMJBQQGMKMT-OXNFMAJFSA-N; [M+H]+; 2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,5,5-trihydroxypyridine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.219; FPHJJCBLRAPJQJ-CRKDRTNXSA-N; [M+Na]+; (2S,3R,4S,5R)-2-amino-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.219; ROPTVRLUGSPXNH-SJLGBTOWNA-N; [M+Na]+; UNPD2640
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.199; ZDTFMPXQUSBYRL-UUOKFMHZSA-N; [M+Na]+; 2-Aminoadenosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.154; DVGWFQILDUEEGX-UUOKFMHZSA-N; [M+Na]+; (2R,3R,4S,5R)-2-(6,8-diaminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.016; DGKZTAGCCXJUAT-UHFFFAOYSA-N; [M+Na]+; 2-(6-hydrazinyl-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.673; LHULZANLATXLRF-UWVGGRQHSA-N; [M+H]+; UNPD221897
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.345; RBWHETGYQFRSRL-UHFFFAOYSA-N; [M+H]+; 1-nitroso-5-[4-(2-nitroso-5-oxopyrazolidin-3-yl)phenyl]pyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.335; PWYIUEFFPNVCMW-UHFFFAOYSA-N; [M+H]+; propaphos
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.335; GZUMLQGDIIYJEA-UHFFFAOYSA-N; [M+H]+; {[2-(4-{2-[(carbamoylamino)imino]acetyl}phenyl)-2-oxoethylidene]amino}urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.686; KWJLIEVAQPLKGV-UHFFFAOYSA-N; [M+Na]+; 5-phenyl-2-phenylsulfanylcyclohexan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; RVTJMJBQQGMKMT-OXNFMAJFSA-N; [M+H]+; 2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,5,5-trihydroxypyridine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.819; GUCKKCMJTSNWCU-JHPDDGAFNA-N; [M+H]+; (2R)-2-[[(3S)-3-acetamido-3-carboxy-1-oxopropyl]amino]pentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.813; OPVPGKGADVGKTG-UHFFFAOYNA-N; [M+H]+; N-Acetylaspartylglutamic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.992; OPVPGKGADVGKTG-BQBZGAKWSA-N; [M+H]+; (2S)-2-[[(2S)-2-acetamido-3-carboxypropanoyl]amino]pentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.361; GUCKKCMJTSNWCU-BQBZGAKWSA-N; [M+H]+; (2S)-2-[[(3S)-3-acetamido-3-carboxypropanoyl]amino]pentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -6.817; OPVPGKGADVGKTG; [M+H]+; Tocris-0391
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -98.330; GUCKKCMJTSNWCU; [M+H]+; Naabak
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -328.641; ZDTFMPXQUSBYRL; [M+Na]+; 2-Aminoadenosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -344.192; DVGWFQILDUEEGX; [M+Na]+; 8-Aminoadenosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -354.089; NHSVFFNZROZDBB; [M+Na]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -356.794; DGKZTAGCCXJUAT; [M+Na]+; 1-Aminoadenosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -380.276; RRIXSWKTPPFTLI; [M+Na]+; 1-amino-2''-deoxyguanosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -393.617; WQZYJWINGYJUHN; [M+Na]+; 3''-Amino-3''-deoxyguanosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -395.861; ROPTVRLUGSPXNH; [M+Na]+; 2-Amino-2-deoxy-ara-G
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -402.249; BLLHHAGUCLNWQL; [M+Na]+; 8-Amino-dG
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -409.783; JUWYSPSHBRXOGR; [M+Na]+; NCIStruc1_000739
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -409.956; JXFCJWXAJPVONT; [M+Na]+; Adenosine, 3''-amino-3''-deoxy-, 1-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -480.126; RVTJMJBQQGMKMT; [M+H]+; PCNR compound
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -487.245; LOOICXPOOTTXRR; [M+Na]+; 2''-O-Glycyl acyclovir
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -507.821; WQBFKZKPIQCPJO; [M+Na]+; Formycine A
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -553.255; DEUZIURSVQYVJZ; [M+Na]+; 4-amino-1-[5-azido-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.600; OPVPGKGADVGKTG; [M+H]+; Tocris-0391
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.154; ZDTFMPXQUSBYRL; [M+Na]+; 2-Aminoadenosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -126.412; OPVPGKGADVGKTG; [M+H]+; N-Acetylaspartylglutamic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -158.127; GUCKKCMJTSNWCU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -395.594; ZDTFMPXQUSBYRL; [M+Na]+; 2-(2,6-diamino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -400.058; CINVHVCPVWRPMT; [M+H]+; beta-D-Glucosyl-hydroxymethyluracil
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -414.989; DGKZTAGCCXJUAT; [M+Na]+; 2-(6-hydrazinyl-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -415.249; DVGWFQILDUEEGX; [M+Na]+; 8-Amionadenosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -434.440; NHSVFFNZROZDBB; [M+Na]+; (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-(azanyloxymethyl)oxolane-3,4-diol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -434.563; RRIXSWKTPPFTLI; [M+Na]+; Guanosine, 1-amino-2'-deoxy-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -438.603; BLLHHAGUCLNWQL; [M+Na]+; 8-Amino-2'-deoxyguanosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -445.006; JUWYSPSHBRXOGR; [M+Na]+; 2-amino-9-[(2R,4R,5R)-5-(aminomethyl)-3,4-dihydroxyoxolan-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -447.103; ROPTVRLUGSPXNH; [M+Na]+; 2'-Amino-2'-Deoxyguanosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -462.715; RVTJMJBQQGMKMT; [M+H]+; 1-Ribosylpyridine-4-one-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -464.199; WQZYJWINGYJUHN; [M+Na]+; 2-amino-9-[(2R,3R,4S,5S)-4-(15N)azanyl-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -479.181; FPHJJCBLRAPJQJ; [M+Na]+; Adenosine amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.437; OPVPGKGADVGKTG; [M+H]+; N-Acetylaspartylglutamic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.147; ZDTFMPXQUSBYRL; [M+Na]+; 2-(2,6-diamino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
COMMENT: CONFIDENCE Level 3: Tentative candidate, N-Acetylaspartylglutamic acid, OPVPGKGADVGKTG-BQBZGAKWSA-N; Proposed by SIRIUS5_CSI with FDR < 0.05; Supported by other software with ranking <= 10 MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0001067;
CH$NAME: N-Acetylaspartylglutamic acid
CH$NAME: (2S)-2-[[(2S)-2-acetamido-3-carboxypropanoyl]amino]pentanedioic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C11H16N2O8
CH$EXACT_MASS: 304.090665
CH$SMILES: CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
CH$IUPAC: InChI=1S/C11H16N2O8/c1-5(14)12-7(4-9(17)18)10(19)13-6(11(20)21)2-3-8(15)16/h6-7H,2-4H2,1H3,(H,12,14)(H,13,19)(H,15,16)(H,17,18)(H,20,21)/t6-,7-/m0/s1
CH$LINK: INCHIKEY OPVPGKGADVGKTG-BQBZGAKWSA-N
CH$LINK: PUBCHEM CID:188803
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.217
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 305.097897
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-8900000000-d958fe4ccc41b3debed7
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0497084 102.0324 56.050421 0.8385 25.46 0.7874 18 f{C3H6N1}/4.15ppm,p-C8H11N1O8
  84.0444402 999.0000 84.045156 0.3570 0.00 0.8351 19 f{C4H6N1O1}/0.59ppm,p-C7H11N1O7
  88.0393646 577.7895 88.040062 0.4657 85.27 0.8982 19 f{C3H6N1O2}/0.68ppm,p-C8H11N1O6
  102.0549258 280.6791 102.055520 0.4997 46.33 0.9596 19 f{C4H8N1O2}/-0.29ppm,p-C7H9N1O6
  130.0499348 646.8305 130.050269 0.4229 72.98 0.7754 19 f{C5H8N1O3}/0.50ppm,p-C6H9N1O5
  148.0604641 710.5496 148.060759 0.4593 104.84 1.0000 19 f{C5H10N1O4}/0.20ppm,p-C6H7N1O4
  158.0449158 91.7283 158.045239 1.3351 23.29 0.7912 16 f{C6H8N1O4}/0.83ppm,p-C5H9N1O4
  194.0446413 87.1267 194.045071 1.1853 25.44 0.8330 14 f{C9H8N1O4}/-0.74ppm,p-C2H9N1O4
  212.0551293 99.2898 212.055550 1.1837 30.55 0.5853 16 f{C9H10N1O5}/-1.04ppm,p-C2H7N1O3
PK$NUM_PEAK: 9
PK$PEAK: m/z int. rel.int.
  56.049708 102.03 102
  84.044440 999.00 999
  88.039365 577.79 577
  102.054926 280.68 280
  130.049935 646.83 646
  148.060464 710.55 710
  158.044916 91.73 91
  194.044641 87.13 87
  212.055129 99.29 99
//
